JP2011036190A - Method for producing granular oral food and granular oral food produced by the method - Google Patents

Method for producing granular oral food and granular oral food produced by the method Download PDF

Info

Publication number
JP2011036190A
JP2011036190A JP2009187212A JP2009187212A JP2011036190A JP 2011036190 A JP2011036190 A JP 2011036190A JP 2009187212 A JP2009187212 A JP 2009187212A JP 2009187212 A JP2009187212 A JP 2009187212A JP 2011036190 A JP2011036190 A JP 2011036190A
Authority
JP
Japan
Prior art keywords
mixture
oral food
plant
granular
fermented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009187212A
Other languages
Japanese (ja)
Inventor
Terumi Takaoka
照海 高岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enseki Aojiru Inc
Original Assignee
Enseki Aojiru Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enseki Aojiru Inc filed Critical Enseki Aojiru Inc
Priority to JP2009187212A priority Critical patent/JP2011036190A/en
Publication of JP2011036190A publication Critical patent/JP2011036190A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for producing granular oral food by which various kinds of efficacies and effects such as health maintenance, improvement in physical condition, improvement in skin condition, prevention from disease or obesity are synergistically obtained; and to provide granular oral food obtained by the method. <P>SOLUTION: The method for producing granular oral food comprises: adding powdery kale B to liquid mixture D where fermented soybean (Aa), yoghurt (Ab) and yeast (Ac) are mixed together to ferment the mixture; heating the fermented mixture D at a temperature high enough to stop or inhibit the activity of the soybean fungi, lactobacillus, yeast and/or the like, or kill the fungi; and processing the heat-treated mixture D into a granular state to produce a granular oral food G. Oral administration of the granular oral food G produced by the method results in resuming the activity of the fungi falling in the granular oral food G in the human body, so that various efficacies and effects such as health maintenance, improvement in physical condition, improvement in skin condition, prevention from disease or obesity can be synergistically obtained. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

この発明は、例えばケール、緑茶、抹茶、発芽玄米、発芽黒豆、シモン芋、ウコンの根、ヤーコンの根、稲若葉、大麦若葉、イチョウ葉、シモン葉、ウコン葉、ヤーコン葉、あした葉、すぎな葉、桑の葉、グァバ葉、よもぎ葉、葛の葉等の経口投与される植物が含まれる顆粒状の経口食品を製造する際に用いられる顆粒状経口食品の製造方法及びその顆粒状経口食品に関する。   This invention is, for example, kale, green tea, green tea, germinated brown rice, germinated black bean, simmon rice, turmeric root, yacon root, rice young leaf, barley young leaf, ginkgo biloba, Simon leaf, turmeric leaf, yacon leaf, tomato leaf, too The present invention relates to a method for producing a granular oral food used in the production of a granular oral food containing plants to be administered orally, such as Japanese leaves, mulberry leaves, guava leaves, wormwood leaves, kuzu leaves, etc., and the granular oral food .

従来、前記大豆が含まれる顆粒状経口食品の製造方法としては、例えば特許文献1の発芽処理大豆を使用した大豆加工品とその製造法がある。この大豆加工品は、水に浸漬した大豆を水切り後、発芽処理を6〜18時間行って得た発芽処理大豆を原料に用いた納豆または豆腐である。また、製造法は、水に浸漬した大豆を水切り後、発芽処理を6〜14時間行い、得られた発芽処理大豆に加水しながら磨砕して生呉を得、該生呉を加熱した後、固−液分離して得た豆乳に凝固剤を添加し、次いで成形するものである。   Conventionally, as a manufacturing method of the granular oral food containing the soybean, there are, for example, a processed soybean product using a germinated soybean of Patent Document 1 and a manufacturing method thereof. This processed soybean product is natto or tofu using germinated soybeans obtained by draining soybeans soaked in water and then germinated for 6 to 18 hours. Moreover, after draining the soybeans immersed in water, a manufacturing method performs after germination processing for 6 to 14 hours, grind | pulverizes while adding water to the germinated soybeans obtained, and obtains raw Kure and heats this Kure Kure The coagulant is added to the soymilk obtained by solid-liquid separation and then molded.

しかし、前記発芽処理大豆を原料とする納豆または豆腐等の大豆加工品には、豆乳が多く含まれているので、前記製造法で製造された大豆加工品を摂取すると豆乳アレルギーを発生することがある。また、豆乳の代わりに、例えば乳牛、山羊等の動物から得られた乳を発酵させても、乳に含まれる脂質の量が豆乳の2倍以上あるため、乳アレルギーの発生率が高い。さらに、動物性の乳であるため、イソフラボンが含まれておらず、例えば美白作用、保湿性の向上、生理不順の改善、肌荒れ、小皺、肥満、シミ、肌の潤い、更年期障害の軽減、骨粗鬆症、動脈硬化、乳癌や前立腺癌の予防等の効果が期待できない。   However, soybean processed products such as natto or tofu made from the germinated soybeans contain a large amount of soy milk, and soy milk allergies may occur when the processed soybean products manufactured by the above-mentioned manufacturing method are consumed. is there. In addition, even when milk obtained from animals such as dairy cows and goats is fermented instead of soy milk, the amount of lipid contained in milk is more than twice that of soy milk, so that the incidence of milk allergy is high. Furthermore, since it is animal milk, it does not contain isoflavones, such as whitening action, improved moisture retention, improved menstrual irregularities, rough skin, wrinkles, obesity, spots, moisture, reduced climacteric disorder, osteoporosis Cannot be expected to prevent arteriosclerosis, breast cancer and prostate cancer.

特開平11−123060号公報JP 11-123060 A

この発明は、例えば健康維持、体質改善、肌質改善、病気や肥満の予防等の様々な効能や効果が相乗して得られる顆粒状経口食品の製造方法及びその顆粒状経口食品の提供を目的とする。   The present invention aims to provide a method for producing a granular oral food obtained by synergizing various effects and effects such as health maintenance, constitution improvement, skin quality improvement, prevention of diseases and obesity, and the like. And

この発明は、蒸し処理された有機栽培の大豆を納豆菌により発酵してなる納豆と、動物から搾乳された乳を乳酸菌により発酵してなるヨーグルトと、単一種を培養してなるイースト菌とを混合する第1の混合工程と、前記第1の混合工程にて混合された液状の混合物に粉末状の植物を添加する添加工程と、前記添加工程にて植物が添加された混合物を適温に保ちながら発酵する発酵工程と、前記発酵工程にて発酵された混合物を、該混合物に含まれる菌の活動が停止又は抑えられる温度で熱処理する熱処理工程と、前記熱処理工程にて熱処理された混合物を顆粒状に加工する顆粒化工程とを備えた顆粒状経口食品の製造方法であることを特徴とする。   This invention is a mixture of natto fermented steamed organically grown soybeans with natto bacteria, yogurt fermented with lactic acid bacteria from milk squeezed from an animal, and yeast strains cultured with a single species A first mixing step, an adding step of adding a powdery plant to the liquid mixture mixed in the first mixing step, while maintaining the mixture to which the plant is added in the adding step at an appropriate temperature Fermentation process for fermentation, heat treatment process for heat treating the mixture fermented in the fermentation process at a temperature at which the activity of bacteria contained in the mixture is stopped or suppressed, and the mixture heat treated in the heat treatment process in a granular form It is a manufacturing method of the granular oral food provided with the granulation process processed into.

この発明の態様として、前記添加工程にて混合物に植物を添加する際に、該混合物と植物を8:10の重量比で混合することができる。   As an aspect of the present invention, when a plant is added to the mixture in the addition step, the mixture and the plant can be mixed at a weight ratio of 8:10.

また、この発明の態様として、前記添加工程にて混合物に植物を添加する際に、有機栽培の農産物から抽出された天然甘味料を添加することができる。   Moreover, as an aspect of this invention, when adding a plant to a mixture at the said addition process, the natural sweetener extracted from the agricultural product of organic cultivation can be added.

また、この発明の態様として、前記発酵工程にて発酵された混合物に、粉末状の植物を混合する第2の混合工程を備えることができる。   Moreover, as an aspect of the present invention, a second mixing step of mixing a powdery plant with the mixture fermented in the fermentation step can be provided.

また、この発明の態様として、前記混合物に添加される植物に遠赤外線を照射して、該植物を所望する水分量に乾燥する植物乾燥工程を備えることができる。   Moreover, the aspect of this invention can be provided with the plant drying process which irradiates a far-infrared ray to the plant added to the said mixture, and dries this plant to the desired moisture content.

また、この発明の態様として、前記混合物に添加される植物を粉末状に粉砕する植物粉砕工程を備えすることができる。   Moreover, the aspect of this invention can be equipped with the plant crushing process which grind | pulverizes the plant added to the said mixture in a powder form.

また、この発明は、蒸し処理された有機栽培の大豆を納豆菌により発酵してなる納豆と、動物から搾乳された乳を乳酸菌により発酵してなるヨーグルトと、単一種を培養してなるイースト菌とが混合された液状の混合物に、粉末状の植物を加えて発酵させた後、前記植物が加えられた混合物を、該混合物に含まれる菌の活動が停止又は抑えられる温度で熱処理して顆粒状に加工した顆粒状経口食品であることを特徴とする。   The present invention also includes natto fermented steamed organically grown soybeans with Bacillus natto, yogurt fermented with lactic acid bacteria from milk squeezed from animals, and yeast produced by culturing a single species. After the powdery plant is added to the liquid mixture in which the mixture is fermented and fermented, the mixture to which the plant is added is heat-treated at a temperature at which the activity of the fungi contained in the mixture is stopped or suppressed, and then granulated. It is characterized by being a granular oral food processed into a powder.

また、この発明の態様として、前記混合物と植物を8:10の重量比で混合することができる。   As an aspect of the present invention, the mixture and the plant can be mixed at a weight ratio of 8:10.

また、この発明の態様として、前記混合物に、有機栽培の農産物から抽出された天然甘味料を添加することができる。   As an embodiment of the present invention, a natural sweetener extracted from organically grown agricultural products can be added to the mixture.

また、この発明の態様として、前記混合物に、遠赤外線の照射によって所望する水分量に乾燥された植物を添加することができる。   Moreover, the plant dried to the moisture content desired by irradiation of a far infrared ray can be added to the said mixture as an aspect of this invention.

前記植物は、例えばケール、緑茶、抹茶、発芽玄米、発芽黒豆、シモン芋、ウコンの根、ヤーコンの根、稲若葉、大麦若葉、イチョウ葉、シモン葉、ウコン葉、ヤーコン葉、あした葉、すぎな葉、桑の葉、グァバ葉、よもぎ葉、葛の葉等の植物の葉や根、穀物、野菜、豆類で構成することができる。
実施例では、成葉段階で収穫されたケール成葉、芽出し野菜の1種であるケールスプラウト等の微粉末を中心核として使用している。
The plant is, for example, kale, green tea, matcha, germinated brown rice, germinated black bean, simmon rice, turmeric root, yacon root, rice young leaf, barley young leaf, ginkgo leaf, Simon leaf, turmeric leaf, yacon leaf, tomato leaf, too Leaves, roots, cereals, vegetables, and beans such as Japanese leaves, mulberry leaves, guava leaves, wormwood leaves, and kuzu leaves.
In the embodiment, fine powder such as kale sprout and kale sprout which is one kind of sprouting vegetables harvested in the mature leaf stage is used as the core.

天然甘味料は、例えば有機栽培の農産物から抽出された黒糖、或いは、ステビア草から抽出されたステビア甘味料等で構成することができる。   The natural sweetener can be composed of, for example, brown sugar extracted from organically grown agricultural products or stevia sweetener extracted from stevia grass.

黒糖には、例えばカルシウム、カリウム、ナトリウム、マグネシウム、マンガン、リン、亜鉛、鉄、銅等のミネラルと、ビタミンB1、B2、ナイアシン、パントテン酸等のビタミン類が豊富に含まれている。   Brown sugar is rich in minerals such as calcium, potassium, sodium, magnesium, manganese, phosphorus, zinc, iron and copper, and vitamins such as vitamins B1, B2, niacin and pantothenic acid.

ステビア草には、例えばステビオサイド、レバウディオサイド等の甘味成分が多量に含まれており、甘味は砂糖の250倍であり、カロリーは90分の1である。   Stevia grass contains a large amount of sweet components such as stevioside and rebaudioside, for example, sweetness is 250 times that of sugar and calories are 90 times smaller.

第1及び第2の混合工程は、例えば納豆、ヨーグルト、イースト菌、粉末状の植物からなる混合物を略均一に混合する混合装置等で構成することができる。   The 1st and 2nd mixing process can be comprised with the mixing apparatus etc. which mix the mixture which consists of natto, yoghurt, yeast, and a powdery plant substantially uniformly, for example.

添加工程は、例えば納豆、ヨーグルト、イースト菌等を混合してなる混合物に粉末状の植物を添加する添加装置等で構成することができる。   An addition process can be comprised by the addition apparatus etc. which add a powdery plant to the mixture formed by mixing natto, yogurt, yeast, etc., for example.

発酵工程は、例えば発酵に適した温度、湿度等に保たれた発酵室や発酵装置等で構成することができる。   A fermentation process can be comprised with the fermentation chamber, the fermentation apparatus, etc. which were maintained at the temperature suitable for fermentation, humidity, etc., for example.

熱処理工程は、例えば納豆菌、乳酸菌、イースト菌等の菌の活動が停止又は抑えられるか、菌が死滅するような温度で熱処理する熱処理装置等で構成することができる。なお、熱処理装置は、例えば遠赤外線を照射する遠赤外線照射装置、放射熱を放射するヒータ装置、熱風を送風する送風装置等で構成することができる。   A heat treatment process can be comprised with the heat processing apparatus etc. which heat-process at the temperature which the activity of bacteria, such as natto bacteria, lactic acid bacteria, yeast, etc. is stopped or suppressed, or a microbe kills, for example. The heat treatment apparatus can be constituted by, for example, a far infrared irradiation apparatus that irradiates far infrared rays, a heater apparatus that radiates radiant heat, a blower apparatus that blows hot air, or the like.

顆粒化工程は、例えば粉砕工程で粉砕された微粉末を、造粒室内の下部から上部に向けて送風される熱風中に噴出するとともに、微粉末からなる中心核の周面全体に、培養工程で作り出された液状の組成物を被覆して顆粒状に加工する流動型造粒装置、或いは、押出し機により押出し成形される線状の原料を所定の粒径サイズに細断し、その細断された原料を転動又は加圧して顆粒状に加工する押出し型造粒装置等で構成することができる。   In the granulation step, for example, the fine powder pulverized in the pulverization step is spouted into hot air blown from the lower part to the upper part of the granulation chamber, and the entire peripheral surface of the central core made of the fine powder is cultured. A fluid type granulator that coats the liquid composition produced in step 1 and processes it into granules, or a linear raw material extruded by an extruder is shredded into a predetermined particle size and then shredded. It can comprise with the extrusion-type granulator etc. which process or pressurize the used raw material and process it into a granular form.

植物乾燥工程は、例えば遠赤外線を照射する遠赤外線照射装置、放射熱を放射するヒータ装置、熱風を送風する送風装置等で構成することができる。
植物粉砕工程は、例えば経口投与される植物を粉末状に粉砕する粉砕装置等で構成することができる。
A plant drying process can be comprised with the far-infrared irradiation apparatus which irradiates a far-infrared ray, the heater apparatus which radiates radiant heat, the air blower which blows hot air etc., for example.
The plant pulverization step can be constituted by, for example, a pulverizer for pulverizing a plant to be orally administered into powder.

この発明によれば、納豆、ヨーグルト、イースト菌が混合された液状の混合物に粉末状の植物を添加して発酵させた後、発酵済みの発酵混合物を菌の活動が停止又は抑えられるか、菌が死滅するような温度で熱処理して顆粒状に加工して顆粒状経口食品を製造する。つまり、本発明の製造方法で製造された顆粒状経口食品を人の体内に経口投与すれば、顆粒状経口食品に含まれる菌が人の体内で活動を再開する。これにより、菌の活動により、例えば健康維持、体質改善、肌質改善、病気や肥満の予防等の様々な効能や効果が相乗して得られる。   According to this invention, after adding a powdery plant to a liquid mixture in which natto, yogurt, and yeast are mixed and fermenting, the activity of the fungus can be stopped or suppressed in the fermented fermented mixture. A granular oral food is produced by heat-treating at a temperature at which it will die, and processed into granules. That is, if the granular oral food produced by the production method of the present invention is orally administered to the human body, the bacteria contained in the granular oral food resume activity in the human body. Thereby, various effects and effects, such as health maintenance, a constitution improvement, skin quality improvement, prevention of illness and obesity, are obtained in synergy by the activity of bacteria.

顆粒状経口食品の製造方法を示す工程図。Process drawing which shows the manufacturing method of granular oral food. 顆粒製造装置による顆粒状経口食品の製造方法を示す説明図。Explanatory drawing which shows the manufacturing method of the granular oral food by a granule manufacturing apparatus. 顆粒状経口食品の内部構造を示す断面図。Sectional drawing which shows the internal structure of granular oral food. 顆粒状に加工された顆粒状経口食品の粒径サイズを示す拡大図。The enlarged view which shows the particle size size of the granular oral food processed into the granular form. 錠剤製造装置にて製造された錠剤状経口食品を示す斜視図。The perspective view which shows the tablet-form oral food manufactured with the tablet manufacturing apparatus. カプセル製造装置にて製造されたカプセル状経口食品を示す斜視図。The perspective view which shows the capsule-form oral food manufactured with the capsule manufacturing apparatus. 顆粒粉砕工程にて粉末状に粉砕された粉末状経口食品を示す拡大図。The enlarged view which shows the powdered oral food grind | pulverized to the powder form in the granule grinding | pulverization process.

図1は、顆粒状経口食品Gの製造方法を示す工程図、図2は、顆粒製造装置1による顆粒状経口食品Gの製造方法を示す説明図、図3は、顆粒状経口食品Gの内部構造を示す断面図、図4は、顆粒状に加工された顆粒状経口食品Gの粒径サイズを示す拡大図、図5は、錠剤製造装置H1にて製造された錠剤状経口食品Gを示す斜視図、図6は、カプセル製造装置H2にて製造されたカプセル状経口食品Gbを示す斜視図、図7は、顆粒粉砕工程hにて粉末状に粉砕された粉末状経口食品Gを示す拡大図である。   FIG. 1 is a process diagram showing a method for producing a granular oral food G, FIG. 2 is an explanatory diagram showing a method for producing the granular oral food G by the granule production apparatus 1, and FIG. Cross-sectional view showing the structure, FIG. 4 is an enlarged view showing the particle size of the granular oral food G processed into granules, and FIG. 5 shows the tablet-like oral food G manufactured by the tablet manufacturing apparatus H1. FIG. 6 is a perspective view showing a capsule-shaped oral food Gb manufactured by the capsule manufacturing apparatus H2, and FIG. 7 is an enlarged view showing the powdered oral food G pulverized into powder in the granule pulverization step h. FIG.

本実施例の顆粒状経口食品Gの製造方法は、蒸し処理された有機栽培の大豆を納豆菌により発酵してなる納豆Aaと、動物の一例である牛から搾乳された牛乳を乳酸菌により発酵してなるヨーグルトAbと、単一種を培養してなるイースト菌Acとを混合する第1混合工程bと、第1混合工程bにて納豆Aa、ヨーグルトAb、イースト菌Acが混合された液状の混合物Dに植物の一例である粉末状のケールBを添加する添加工程cと、添加工程cにて粉末状のケールBが添加された混合物Dを適温に保ちながら発酵する発酵工程dと、発酵工程dにて発酵された混合物Dに粉末状のケールBを混合する第2混合工程eと、第2混合工程eにてケールBが混合された混合物Dを、該混合物Dに含まれる複数種の菌の活動が停止又は抑えられる温度で熱処理する熱処理工程fと、熱処理工程fにて熱処理された混合物Dを顆粒状に加工する顆粒化工程gと、顆粒化工程gにて顆粒化された顆粒状経口食品Gを粉末状に粉砕する顆粒粉砕工程hと、顆粒粉砕工程hにて粉末化された粉末状経口食品G3或いは顆粒化工程gにて顆粒化された顆粒状経口食品Gを錠剤状経口食品Gaに加工する食品化工程iとを備えている。   The manufacturing method of the granular oral food G of a present Example ferments natto Aa which fermented the steamed organically grown soybean with natto bacteria, and milk milked from the cow which is an example of an animal with lactic acid bacteria. To the liquid mixture D in which the natto Aa, the yogurt Ab, and the yeast fungus Ac are mixed in the first mixing step b. Addition step c for adding powdered kale B, which is an example of a plant, fermentation step d for fermenting the mixture D to which powdered kale B is added in the addition step c while maintaining an appropriate temperature, and fermentation step d A second mixing step e in which the powdered kale B is mixed with the fermented mixture D, and a mixture D in which the kale B is mixed in the second mixing step e. Activity is stopped or suppressed Heat treatment step f for heat treatment at a degree, granulation step g for processing mixture D heat-treated in heat treatment step f into granules, and granular oral food G granulated in granulation step g in powder form Granulation step h for pulverization, and powdered oral food G3 pulverized in the granulation pulverization step h or granular oral food G pulverized in the granulation step g to be processed into a tablet-like oral food Ga And step i.

第1混合工程bでは、蒸し処理された有機栽培の大豆を納豆菌により1次発酵してなる納豆Aaと、牛から搾乳された牛乳を乳酸菌により1次発酵してなるヨーグルトAbと、単一種を培養及び1次発酵してなるイースト菌Acとを、図示しない混合装置により略均一に混合して、液状の混合物Dを作り出す。   In the first mixing step b, natto Aa obtained by primary fermentation of steamed organically grown soybeans with natto bacteria, yogurt Ab obtained by primary fermentation of milk milked from cows with lactic acid bacteria, and a single species Yeast bacteria Ac obtained by culturing and primary fermentation is mixed substantially uniformly by a mixing device (not shown) to produce a liquid mixture D.

納豆Aaは、有機栽培された大豆を、図示しない蒸し器や蒸し装置を用いて蒸し処理した後、該蒸し処理された大豆全体に対し納豆菌を均等に付着させる。この後、納豆菌が付着した大豆を、発酵に適した温度、湿度等に保たれた発酵室にて発酵させ、大豆を納豆菌により発酵させて製造したものである。   Natto Aa steams organically cultivated soybeans using a steamer or steaming device (not shown), and then uniformly attaches natto bacteria to the whole steamed soybeans. Thereafter, the soybeans to which natto bacteria are adhered are fermented in a fermentation chamber maintained at a temperature and humidity suitable for fermentation, and the soybeans are produced by fermentation with natto bacteria.

つまり、納豆Aaを摂取すれば、例えば脳卒中・脳梗塞、視力・目の疲れ、頭痛・鎮痛、脱毛、味覚障害、喘息・咳、肩こり、血栓、心臓病・心臓疾患・心筋梗塞、胃炎・胃潰瘍・胃腸病、肝炎・肝臓病・肝機能、腎炎・腎臓病・腎機能、ニキビ・吹き出物、美肌・しみ・そばかす、関節炎、前立腺肥大症、生理不順・生理痛、利尿、便秘・整腸、下痢、免疫力、新陳代謝、ダイエット、疲労回復、豊胸、老化、更年期障害、アトピー・アレルギー、強精・強壮、不眠症、ガン、糖尿病、高血圧、コレステロール・高脂血症・動脈硬化、リウマチ、骨粗鬆症、神経痛、冷え性、貧血、痴呆症、抗菌・抗ウイルス、乳癌や前立腺癌の予防等の効能や効果が得られる。   In other words, if you take natto Aa, for example, stroke / cerebral infarction, visual acuity / eye fatigue, headache / analgesic, hair loss, taste disorder, asthma / cough, shoulder stiffness, thrombus, heart disease / heart disease / myocardial infarction, gastritis / gastric ulcer・ Gastrointestinal disease, hepatitis / liver disease / liver function, nephritis / kidney disease / renal function, acne / pimple, beautiful skin / stain / freckle, arthritis, prostatic hypertrophy, irregular menstruation / menstrual pain, diuresis, constipation / intestine, diarrhea , Immunity, metabolism, diet, recovery from fatigue, breast augmentation, aging, climacteric disorder, atopy, allergies, hypertension, tonic, insomnia, cancer, diabetes, hypertension, cholesterol, hyperlipidemia / arteriosclerosis, rheumatism, osteoporosis Efficacy and effects such as neuralgia, chilliness, anemia, dementia, antibacterial / antiviral, breast cancer and prostate cancer prevention can be obtained.

ヨーグルトAbは、牛から搾乳された牛乳を40℃〜45℃に加温した後、その加温された牛乳に乳酸菌を混ぜて発酵させた発酵乳である。
つまり、ヨーグルトAbに含まれる乳酸菌は、例えば乳糖、タンパク質、ビタミン、カルシウム等の牛乳に含まれる栄養素を体内へ吸収されやすいものに変化させる効果がある。例えばたんぱく質の一部が分解されてアミノ酸に変化するため、体内で消化・吸収されやすくなる。
Yogurt Ab is fermented milk obtained by heating milk extracted from a cow to 40 ° C. to 45 ° C., and then fermenting the heated milk with lactic acid bacteria.
That is, lactic acid bacteria contained in yogurt Ab have an effect of changing nutrients contained in milk such as lactose, protein, vitamins, calcium and the like to be easily absorbed into the body. For example, part of the protein is broken down into amino acids, making it easier to digest and absorb in the body.

これにより、乳幼児から高齢の人、病気の人が摂取することができる。また、栄養素の摂取により、例えば癌予防、高血圧、糖尿病等を予防する効果が得られる。
また、乳酸菌が乳糖をエサにして作り出す乳酸や酢酸は、胃や腸のぜん動運動、消化吸収を高めて、便秘の予防及び腸内のバランスを調整する。
Thereby, an elderly person and a sick person can ingest from an infant. Moreover, the effect of preventing cancer, hypertension, diabetes and the like can be obtained by ingesting nutrients.
In addition, lactic acid and acetic acid produced by lactobacilli using lactose as a feed increases peristaltic movement and digestive absorption of the stomach and intestines, preventing constipation and adjusting the intestinal balance.

さらに、乳酸菌は、腸内のビフィズス菌を増加させるので、病気の原因となる悪玉菌の増殖を抑えるとともに、悪玉菌が作り出す有害物質を吸着して排出する。また、免疫力を高める作用があるので、抵抗力がついて病気になりにくくなる等の効果が得られる。
なお、牛から搾乳する代わりに、例えばヤギ、ヒツジ等の動物から搾乳した乳を用いてもよい。
Furthermore, since lactic acid bacteria increase the number of bifidobacteria in the intestines, they suppress the growth of bad bacteria that cause illness and adsorb and discharge harmful substances produced by bad bacteria. Moreover, since it has the effect | action which raises immunity, effects, such as resisting and becoming difficult to get sick, are acquired.
In place of milking from cows, milk milked from animals such as goats and sheep may be used.

イースト菌Acは、酵母菌の一種であり、単一種のイースト菌Acのみを純粋培養したものであり、糖分をアルコールに変える働きを持っている。また、イースト菌Acには、水分、たんぱく質、ビタミン、ミネラル、炭水化物、脂質等が含まれている。なお、イースト菌の代わりに、その他の酵母菌を用いてもよい。   Yeast bacterium Ac is a kind of yeast, which is a pure culture of only a single type of yeast bacterium Ac, and has a function of changing sugar to alcohol. In addition, yeast, Ac, contains water, protein, vitamins, minerals, carbohydrates, lipids, and the like. In addition, other yeasts may be used instead of yeast.

第1混合工程bにて混合される納豆Aaを、有機栽培された大豆を発芽させて蒸し処理した後、その蒸し処理された大豆を納豆菌により発酵させてなる納豆Aaを使用してもよい。   Natto Aa mixed in the first mixing step b may be natto Aa produced by germinating organically grown soybeans and steaming, and then fermenting the steamed soybeans with natto bacteria. .

つまり、有機栽培された大豆を、図示しない発芽装置により所定時間栽培して発芽すれば、大豆に含まれるγ−アミノ酪酸及び必須アミノ酸が発芽前よりも富化する。これにより、発芽前の大豆からなる納豆Aaに比べて、発芽後の大豆からなる納豆Aaに含まれるイソフラボンの量を4倍以上にも増加させることができる。   That is, if organically cultivated soybeans are cultivated for a predetermined time with a germination device (not shown), γ-aminobutyric acid and essential amino acids contained in the soybean are enriched more than before germination. Thereby, compared with natto Aa which consists of soybeans before germination, the quantity of isoflavone contained in natto Aa which consists of soybeans after germination can be increased 4 times or more.

また、第1混合工程bの前段に、蒸し処理前又は蒸し処理後の大豆に対し遠赤外線を照射する遠赤外線照射工程を設けてもよい。
つまり、有機栽培の大豆全体に、図示しない遠赤外線照射装置から発射される遠赤外線を略均等に照射する。
Moreover, you may provide the far-infrared irradiation process which irradiates far infrared rays with respect to the soybean before a steaming process or after a steaming process in the front | former stage of the 1st mixing process b.
That is, far-infrared rays emitted from a far-infrared ray irradiation device (not shown) are irradiated almost uniformly on the whole organically grown soybean.

大豆に含まれるグルタミン酸がγ−アミノ酪酸(いわゆるGABA)及び必須アミノ酸に変化し、γ−アミノ酪酸及び必須アミノ酸の富化を図ることができる。
これにより、例えば血圧上昇抑制作用、精神安定作用、腎機能改善作用、肝機能改善作用、肥満防止作用、口臭や体臭などの消臭効果が得られる。
The glutamic acid contained in soybean changes to γ-aminobutyric acid (so-called GABA) and essential amino acids, and enrichment of γ-aminobutyric acid and essential amino acids can be achieved.
Thereby, for example, a blood pressure increase suppressing action, a tranquilizing action, a renal function improving action, a liver function improving action, an obesity preventing action, and a deodorizing effect such as bad breath and body odor can be obtained.

また、必須アミノ酸は体内で生合成することが不可能なアミノ酸であって、この必須アミノ酸(旨味成分)の富化により、大豆を主原料とする顆粒状経口食品Gの美味しさ及び食感を向上させることができる。   In addition, essential amino acids are amino acids that cannot be biosynthesized in the body. By enriching these essential amino acids (flavoring ingredients), the taste and texture of the granular oral food G mainly made of soybeans are improved. Can be improved.

添加工程cでは、第1混合工程bにて納豆Aa、ヨーグルトAb、イースト菌Acが混合された液状の混合物Dに、後述する植物粉砕工程kにて粉砕された粉末状のケールBを、図示しない添加装置により添加する。   In the addition step c, the powdery kale B pulverized in the plant pulverization step k described later is not illustrated in the liquid mixture D in which the natto Aa, the yogurt Ab, and the yeast fungus Ac are mixed in the first mixing step b. Add with addition device.

実施例では、液状の混合物Dと粉末状のケールBを、8:10の重量比で混合しているが、例えば混合物Dを8以下又は8以上、ケールBを10以下又は10以上に変更するなど、混合物DとケールBの重量比を、所望する重量比に変更してもよい。   In the embodiment, the liquid mixture D and the powdery kale B are mixed at a weight ratio of 8:10. For example, the mixture D is changed to 8 or less or 8 or more, and the kale B is changed to 10 or less or 10 or more. For example, the weight ratio of the mixture D and the kale B may be changed to a desired weight ratio.

なお、ケールBは、成葉段階で収穫されるため、例えばビタミン類やβ-カロチン、食物繊維、たんぱく質、カルシウム、マグネシウム等のミネラルが豊富に含まれている。
また、ケールBの粉末を添加する代わりに、例えば芽出し野菜の1種であるケールスプラウトの粉末を添加してもよい。
Since kale B is harvested at the mature leaf stage, it is rich in vitamins, β-carotene, dietary fiber, protein, calcium, magnesium and other minerals.
Further, instead of adding the kale B powder, for example, kale sprout powder, which is a kind of sprouting vegetable, may be added.

添加工程cにて粉末状のケールBを混合物Dに添加する際に、例えば天然甘味料の一例である有機栽培の農産物から抽出された有機黒糖Cを添加してもよい。   When adding the powdery kale B to the mixture D in the addition step c, for example, organic brown sugar C extracted from organically grown agricultural products, which is an example of a natural sweetener, may be added.

つまり、粉末状のケールBが添加された混合物Dに対し有機黒糖Cを添加することにより、後述する発酵工程dにて混合物Dの発酵が促進され、カリウム、カルシウム、リン、鉄、ビタミンB1、ビタミンE、サポニン、イソフラボノイド及び各種ポリフェノール類等のミネラルが富化される効果が相乗して得られる。   That is, by adding organic brown sugar C to mixture D to which powdery kale B is added, fermentation of mixture D is promoted in fermentation step d described later, and potassium, calcium, phosphorus, iron, vitamin B1, Synergistic effects of enriching minerals such as vitamin E, saponins, isoflavonoids and various polyphenols are obtained.

混合物D及びケールBを混合して発酵させるよりも、有機黒糖Cを添加して発酵させたほうが、混合物Dの脂質量が少なくなり、豆乳アレルギーが発生するのを抑制して、発生率を低減する効果が得られる。
なお、有機黒糖Cの代わりに、ステビア草から抽出されたステビア甘味料を天然甘味料として用いてもよい。
Compared to fermenting mixture D and kale B, adding organic brown sugar C and fermenting reduces the amount of lipid in mixture D and suppresses the occurrence of soymilk allergy, reducing the incidence Effect is obtained.
Instead of organic brown sugar C, a stevia sweetener extracted from stevia grass may be used as a natural sweetener.

発酵工程dでは、添加工程cにて粉末状のケールBが添加された混合物Dを、該混合物Dの発酵が促進される温度に保ちながら図示しない発酵装置により発酵させる。   In the fermentation step d, the mixture D to which the powdered kale B is added in the addition step c is fermented by a fermentation apparatus (not shown) while maintaining the temperature at which the fermentation of the mixture D is promoted.

つまり、発酵時の分解作用によって混合物Dの脂質及びケールBが分子細分化されるので、体内への吸収効率が向上する。また、混合物Dの脂質量が減少するので、豆乳アレルギーが発生するのを抑制して、発生率を低減する効果が得られる。   That is, the lipid and the kale B of the mixture D are molecularly subdivided by the decomposition action during fermentation, so that the absorption efficiency into the body is improved. Moreover, since the lipid amount of the mixture D decreases, the effect of suppressing the occurrence of soymilk allergy and reducing the incidence can be obtained.

第2混合工程eでは、発酵工程dにて発酵された混合物Dに、後述する植物乾燥工程jにて所望する水分量に乾燥され、次の植物粉砕工程kにて粉砕された粉末状のケールBを添加する。また、該ケールBが添加された混合物Dを、図示しない混合装置により略均一に混合して、混合物Dを作り出す。   In the 2nd mixing process e, the powdery kale dried to the moisture content desired in the plant drying process j mentioned later to the mixture D fermented in the fermentation process d, and pulverized in the following plant crushing process k Add B. Further, the mixture D to which the kale B is added is mixed substantially uniformly by a mixing device (not shown) to create the mixture D.

熱処理工程fでは、第2混合工程eにて粉末状のケールBが混合された混合物Dを、図示しない熱処理装置により混合物Dに含まれる複数種の菌(納豆菌、乳酸菌、イースト菌等)の活動が停止又は抑えられる温度で熱処理する。つまり、混合物Dに含まれる菌の活動を停止又は抑えるか、菌を死滅させる。   In the heat treatment step f, the activity of a plurality of types of bacteria (natto, lactic acid bacteria, yeast, etc.) contained in the mixture D by the heat treatment apparatus (not shown) with the mixture D in which the powdered kale B is mixed in the second mixing step e Is heat-treated at a temperature at which is stopped or suppressed. That is, the activity of the bacteria contained in the mixture D is stopped or suppressed, or the bacteria are killed.

混合物Dに混合された納豆Aaに含まれる納豆菌の胞子は、140℃の高温で約1時間熱処理すれば死滅するが、熱処理温度を140℃以下に設定し、熱処理時間を1時間より短くすれば、納豆菌の胞子が死滅することはない。   Spores of Bacillus natto contained in Natto Aa mixed with Mixture D will die if heat-treated for about 1 hour at a high temperature of 140 ° C. However, the heat treatment temperature should be set to 140 ° C. or lower and the heat treatment time should be shorter than 1 hour. For example, the Bacillus natto spores will not die.

つまり、混合物Dを、140℃以下の温度で熱処理すれば、納豆菌の胞子を除いて、雑菌のみを死滅させることができる。
これにより、顆粒化工程gで作り出される顆粒状経口食品Gを経口投与すれば、納豆菌を摂取することができ、前述の納豆Aaによる効能や効果が得られる。
That is, if the mixture D is heat-treated at a temperature of 140 ° C. or less, only miscellaneous bacteria can be killed except for the spore of Natto.
Thereby, if the granular oral food G produced by the granulation process g is orally administered, natto bacteria can be ingested, and the effects and effects of the natto Aa can be obtained.

顆粒化工程gでは、熱処理工程fにて熱処理された液状の混合物Dを、図2に示す顆粒製造装置1の造粒室2内に投入されたケールBの微粉末Baに付着させながら熱風3により乾燥させて、図3、図4に示すような顆粒状経口食品Gを作り出す。   In the granulation step g, the hot mixture 3 is heated while adhering the liquid mixture D heat-treated in the heat treatment step f to the fine powder Ba of kale B introduced into the granulation chamber 2 of the granule production apparatus 1 shown in FIG. To produce a granular oral food G as shown in FIGS.

造粒室2内の下部には、多数の通気孔を有する受け板2aが水平に架設されている。また、該受け板2aの下部には、造粒室2内に向けて熱風3を送気するための図示しない熱風発生装置が接続されている。   In the lower part of the granulation chamber 2, a receiving plate 2a having a large number of ventilation holes is laid horizontally. A hot air generator (not shown) for sending hot air 3 toward the inside of the granulation chamber 2 is connected to the lower part of the receiving plate 2a.

造粒室2の上部には、茶葉Aの乾燥に使用された熱風3を室外に向けて排気するための図示しない熱風排気装置が接続されている。また、該造粒室2内の上部には、熱処理工程fから供給される液状の混合物Dを、造粒室2内に投入されたケールBの微粉末Baに向けて霧状に散布するための噴射装置2b,2bが設けられている。   Connected to the upper part of the granulation chamber 2 is a hot air exhaust device (not shown) for exhausting the hot air 3 used for drying the tea leaves A toward the outside of the room. Further, in the upper part of the granulation chamber 2, the liquid mixture D supplied from the heat treatment step f is sprayed in the form of a mist toward the fine powder Ba of the kale B introduced into the granulation chamber 2. Injection devices 2b, 2b are provided.

つまり、粉砕工程cで粉砕されたケールBの微粉末Baを、図2に示す顆粒製造装置1の造粒室2内に投入した後、図示しない熱風発生装置から供給される熱風3を造粒室2内の下部から上部に向けて送風し、培養工程aで培養された液状の混合物Dを噴射装置2b,2bから噴射して、熱風3中に放出される微粉末Baの周面全体に吹き付けて凝集する。   That is, after the fine powder Ba of kale B pulverized in the pulverization step c is put into the granulation chamber 2 of the granule production apparatus 1 shown in FIG. 2, the hot air 3 supplied from a hot air generator (not shown) is granulated. The air is blown from the lower part to the upper part in the chamber 2, and the liquid mixture D cultured in the culturing step a is injected from the injection devices 2 b and 2 b to the entire peripheral surface of the fine powder Ba released into the hot air 3. Spray to agglomerate.

すなわち、液状の混合物Dを、微粉末Baの周面全体に対し略均一に連続して吹き付けるとともに、略100℃前後の高温に加熱された熱風3により微粉末Baの周面全体に付着された液状の混合物Dと、微粉末Baの内部とから水分を蒸発させて乾燥する。   That is, the liquid mixture D was sprayed almost uniformly and continuously on the entire peripheral surface of the fine powder Ba, and adhered to the entire peripheral surface of the fine powder Ba by hot air 3 heated to a high temperature of about 100 ° C. Water is evaporated from the liquid mixture D and the inside of the fine powder Ba and dried.

これにより、微粉末Baを中心核として、該微粉末Baの周面全体に対し混合物Dからなる略均等な厚みの層が形成される(図3参照)。また、液状の混合物Dを、微粉末Baの周面全体に対し吹き付ける処理を何回か繰り返してもよい。   As a result, a layer having a substantially uniform thickness made of the mixture D is formed on the entire peripheral surface of the fine powder Ba with the fine powder Ba as a central core (see FIG. 3). Moreover, you may repeat the process which sprays the liquid mixture D with respect to the whole surrounding surface of fine powder Ba several times.

この後、微粉末Baの周面全体が混合物Dで被覆された顆粒状経口食品Gを造粒室2から取り出せば、図3、図4に示す顆粒状経口食品Gの製造が完了する。   Thereafter, when the granular oral food G in which the entire peripheral surface of the fine powder Ba is coated with the mixture D is taken out from the granulation chamber 2, the production of the granular oral food G shown in FIGS. 3 and 4 is completed.

また、微粉末Aaの周面全体に対し混合物Dを凝集させる際の粘着剤或いは組成物として、例えばデキストリン、不溶性デンプン等の添加物を混合物Dに添加してもよい。   Moreover, you may add additives, such as dextrin and an insoluble starch, to the mixture D as an adhesive or a composition at the time of making the mixture D aggregate with respect to the whole surrounding surface of fine powder Aa.

微粉末Baの周面全体に形成される混合物Dの層の厚みを異ならせれば、粒径サイズが異なる異径状経口食品G1(図4の4−a参照)を製造することができる。   If the thickness of the layer of the mixture D formed on the entire peripheral surface of the fine powder Ba is varied, different diameter oral foods G1 (see 4-a in FIG. 4) having different particle sizes can be produced.

また、微粉末Baの周面全体に形成される混合物Dの層の厚みを同一にすれば、粒径サイズが同一の同径状経口食品G2(図4の4−b参照)を製造することができる。
また、微細な顆粒状経口食品Gを凝集させて、所望する粒径サイズの顆粒状経口食品Gを製造してもよい。
Moreover, if the thickness of the layer of the mixture D formed on the entire peripheral surface of the fine powder Ba is the same, the same diameter oral food G2 having the same particle size (see 4-b in FIG. 4) is manufactured. Can do.
Alternatively, the granular oral food G may be aggregated to produce a granular oral food G having a desired particle size.

顆粒粉砕工程hでは、顆粒化工程gにて加工された顆粒状経口食品Gを図示しない粉砕装置により粉末状に粉砕して、経口投与される粉末状経口食品G3を製造する(図7参照)。実施例では、顆粒状経口食品Gを、1mm程度の大きさを有する粉末状経口食品G3に粉砕するが、1mm以下又は1mm以上の大きさに粉砕してもよい。   In the granule pulverization step h, the granular oral food G processed in the granulation step g is pulverized into a powder by a pulverization apparatus (not shown) to produce a powdered oral food G3 to be administered orally (see FIG. 7). . In the embodiment, the granular oral food G is pulverized into a powdered oral food G3 having a size of about 1 mm, but may be pulverized to a size of 1 mm or less or 1 mm or more.

食品化工程iでは、顆粒化工程gにて加工された顆粒状経口食品G、或いは、顆粒粉砕工程hにて粉砕された粉末状経口食品G3を、図示しない造粒機や打錠機等の錠剤製造装置H1により造粒又は打錠して、図5に示すような経口食品Ga1,Ga2,Ga3に食品化する。   In the food production step i, the granular oral food G processed in the granulation step g or the powdered oral food G3 pulverized in the granule pulverization step h is used in a granulator, a tableting machine or the like (not shown). It is granulated or tableted by the tablet manufacturing apparatus H1, and is made into foods as oral foods Ga1, Ga2, Ga3 as shown in FIG.

つまり、図5に示すような楕円形状の経口食品Ga1(図5の5−a参照)、三角形状の経口食品Ga2(図5の5−b参照)、四角形状の経口食品Ga3(図5の5−c参照)等の形状を有する錠剤状の経口食品Gaを製造することができる。
なお、前記造粒形状又は打錠形状の他の例として、例えば菱形状、星形状、或いは、動物やキャラクター等の所望する錠剤形状に製造してもよい。
That is, the oval oral food Ga1 (see 5-a in FIG. 5), the triangular oral food Ga2 (see 5-b in FIG. 5), and the rectangular oral food Ga3 (see FIG. 5) as shown in FIG. A tablet-like oral food Ga having a shape such as 5-c) can be produced.
In addition, as another example of the granulated shape or tableted shape, for example, a diamond shape, a star shape, or a desired tablet shape such as an animal or a character may be manufactured.

前記植物乾燥工程jでは、成葉段階で収穫されたケールBに、図示しない遠赤外線照射装置から発射される遠赤外線を照射するとともに、所望する低い温度で加熱して、所望の水分量に乾燥させる。   In the plant drying step j, the kale B harvested in the mature leaf stage is irradiated with far infrared rays emitted from a far infrared irradiation device (not shown) and heated at a desired low temperature to be dried to a desired moisture content. Let

つまり、水分やアルコール分等をケールBから蒸発させて、所定の水分量に乾燥させることにより、ケールBに含まれるグルタミン酸が変化し、γ−アミノ酪酸及び必須アミノ酸の富化を図ることができる。
なお、遠赤外線に代わる他の乾燥方法として、例えばヒータから放射される放射熱、ブロワから送風される温風等で乾燥してもよい。また、乾燥時の温度を、例えば25℃よりも低い温度或いは30℃よりも高い温度に変更してもよい。
That is, by evaporating moisture, alcohol, and the like from kale B and drying to a predetermined moisture content, glutamic acid contained in kale B changes, and enrichment of γ-aminobutyric acid and essential amino acids can be achieved. .
In addition, as another drying method replacing the far-infrared ray, for example, drying may be performed with radiant heat radiated from a heater, warm air blown from a blower, or the like. Moreover, you may change the temperature at the time of drying into the temperature lower than 25 degreeC or the temperature higher than 30 degreeC, for example.

植物粉砕工程kでは、植物乾燥工程jにて乾燥されたケールBを、図示しない粉砕装置により所望するサイズに粉砕する。
つまり、添加工程c及び第2混合工程eの混合物Dに対し略均一に混合されやすい大きさに粉砕する。実施例では、微粉末Baの粒径が100μm以下、望ましくは約0.5μm〜約80μmの範囲に含まれる粒径に粉砕するが、約70μmの粒径が好ましい。
In the plant crushing step k, the kale B dried in the plant drying step j is crushed to a desired size by a crushing device (not shown).
That is, it grind | pulverizes to the magnitude | size which is easy to mix substantially uniformly with respect to the mixture D of the addition process c and the 2nd mixing process e. In the examples, the fine powder Ba has a particle size of 100 μm or less, desirably a particle size in the range of about 0.5 μm to about 80 μm, with a particle size of about 70 μm being preferred.

前記錠剤製造装置H1で製造された錠剤状経口食品Gaは、顆粒化工程gにて加工された顆粒状経口食品Gを押し固めて製造したものであり、顆粒状経口食品Gの粒径が異なれば、錠剤状経口食品Gaを食べた際に、噛み砕くときの力がサイズによって異なり、様々な食感及び舌触り感が得られる。
また、顆粒状経口食品Gの粒径が同一であれば、錠剤状経口食品Gaを食べた際に、噛み砕くときの力が一定しており、安定した食感及び舌触り感が得られる。
The tablet-shaped oral food Ga manufactured by the tablet manufacturing apparatus H1 is manufactured by pressing the granular oral food G processed in the granulating step g, and the granular oral food G has a different particle size. For example, when the tablet-like oral food Ga is eaten, the force for chewing varies depending on the size, and various textures and textures can be obtained.
In addition, if the granular oral food G has the same particle size, when the tablet-like oral food Ga is eaten, the force when chewing is constant, and a stable texture and texture can be obtained.

食品化工程iにおいて、顆粒化工程gにて加工された顆粒状経口食品G或いは顆粒粉砕工程hにて加工された粉末状経口食品G3を、錠剤製造装置H1により造粒又は打錠して、図5に示すような経口食品Ga1,Ga2,Ga3を製造する。   In the food production step i, the granular oral food G processed in the granulation step g or the powdered oral food G3 processed in the granule crushing step h is granulated or tableted by the tablet manufacturing apparatus H1, Oral food Ga1, Ga2, Ga3 as shown in FIG. 5 is manufactured.

また、カプセル製造装置H2により所望する大きさ及び形状に形成されたカプセルに充填すれば、図6に示すようなハードカプセル入りの経口食品Gb1(図6の6−a参照)、ソフトカプセル入りの経口食品Gb2(図6の6−b参照)等のカプセルタイプを有するカプセル状経口食品Gbを製造することができる。   Moreover, when filled into capsules formed in a desired size and shape by the capsule manufacturing apparatus H2, oral food Gb1 containing hard capsules as shown in FIG. 6 (see 6-a in FIG. 6), oral food containing soft capsules Capsule oral food Gb having a capsule type such as Gb2 (see 6-b in FIG. 6) can be produced.

実施例の製造方法で製造された顆粒状経口食品Gと、錠剤状経口食品Gaと、カプセル状経口食品Gbとは、図示しない充填装置により袋、缶、瓶、プラスチック容器等に充填して出荷する。或いは、図示しない包装装置(PTP包装機)によりアルミ箔やフィルム等で包装してもよい。   The granular oral food G, the tablet-shaped oral food Ga, and the capsule-shaped oral food Gb manufactured by the manufacturing method of the embodiment are filled in a bag, can, bottle, plastic container, etc. with a filling device (not shown) before shipment. To do. Or you may wrap with aluminum foil, a film, etc. with the packaging apparatus (PTP packaging machine) which is not illustrated.

つまり、実施例の製造方法で製造された異径状経口食品G1及び同径状経口食品G2を含む顆粒状経口食品Gと、経口食品Ga1,Ga2,Ga3を含む錠剤状経口食品Gaと、経口食品Gb1,Gb2を含むカプセル状経口食品Gbと、粉末状経口食品G3の中から経口投与される経口食品を選択することができる。   That is, the granular oral food G including the different-diameter oral food G1 and the same-diameter oral food G2 manufactured by the manufacturing method of the example, the tablet-shaped oral food Ga including the oral foods Ga1, Ga2, and Ga3, and the oral Oral foods to be orally administered can be selected from among capsule oral foods Gb containing foods Gb1 and Gb2 and powdered oral foods G3.

以上のように、納豆Aa、ヨーグルトAb、イースト菌Acが混合された液状の混合物Dに粉末状のケールBを添加して発酵させた後、発酵済みの混合物Dを、例えば納豆菌、乳酸菌、イースト菌等の菌の活動が停止又は抑えられるか、菌が死滅するような温度で熱処理してから顆粒状に加工して、錠剤状経口食品Ga、カプセル状経口食品Gb、粉末状経口食品G3の元となる顆粒状経口食品Gを製造する。   As described above, after adding fermented kale B to the liquid mixture D in which natto Aa, yogurt Ab, and yeast bacterium Ac are mixed and fermented, the fermented mixture D is treated with, for example, natto, lactic acid bacterium, and yeast bacterium. The activity of bacteria such as bacteria is stopped or suppressed, or heat treated at a temperature at which the bacteria are killed, and then processed into granules, and then the source of tablet-like oral food Ga, capsule-like oral food Gb, powdered oral food G3 A granular oral food G is produced.

つまり、本実施例の製造方法で製造された顆粒状経口食品Gを人の体内に経口投与するか、顆粒状経口食品Gからなる錠剤状経口食品Ga、カプセル状経口食品Gb、粉末状経口食品G3を人の体内に経口投与すれば、顆粒状経口食品Gに含まれる納豆菌、乳酸菌、イースト菌等の中から一つの菌(納豆菌)或いは複数の菌が人の体内で活動を再開する。これにより、例えば健康維持、体質改善、肌質改善、病気や肥満の予防等の様々な効能や効果が相乗して得られる。   That is, the granular oral food G produced by the production method of this embodiment is orally administered to the human body, or the tablet-shaped oral food Ga comprising the granular oral food G, the capsule oral food Gb, and the powdered oral food. If G3 is orally administered to the human body, one bacterium (natto bacterium) or a plurality of bacteria among the natto bacteria, lactic acid bacteria, yeast bacteria, etc. contained in the granular oral food G will resume activity in the human body. As a result, various effects and effects such as health maintenance, constitution improvement, skin quality improvement, prevention of illness and obesity can be obtained in synergy.

また、有機栽培された大豆からなる納豆Aaの脂質を発酵分解してなる顆粒状経口食品Gを適量経口投入することにより、豆乳アレルギーが発生するのを抑制して、発生率の低減を図ることができる。   In addition, by introducing an appropriate amount of granular oral food G obtained by fermentative decomposition of natto Aa lipids made from organically grown soybeans, the occurrence of soymilk allergy is suppressed and the incidence is reduced. Can do.

また、納豆Aaに含まれるイソフラボンの量を増加させて、例えば美白作用、保湿性の向上、生理不順の改善、肌荒れ、小皺、肥満、シミ、肌の潤い、更年期障害の軽減、骨粗鬆症、動脈硬化、乳癌や前立腺癌の予防等の効果を十分に得ることができる。
また、納豆Aaに含まれるγ−アミノ酪酸及び必須アミノ酸を富化させて、例えば血圧上昇抑制作用、精神安定作用、腎機能改善作用、肝機能改善作用、肥満防止作用、口臭や体臭などの消臭効果が得られるとともに、納豆Aaを主原料とする顆粒状経口食品Gの美味しさ及び食感を向上させることができる。
Also, by increasing the amount of isoflavone contained in natto Aa, for example, whitening effect, improvement of moisture retention, improvement of menstrual irregularities, rough skin, small wrinkles, obesity, spots, moisture of skin, reduction of menopause, osteoporosis, arteriosclerosis In addition, effects such as prevention of breast cancer and prostate cancer can be sufficiently obtained.
In addition, γ-aminobutyric acid and essential amino acids contained in natto Aa are enriched to suppress, for example, blood pressure elevation inhibiting effect, tranquilizing effect, renal function improving effect, liver function improving effect, obesity preventing effect, bad breath and body odor. While the odor effect is obtained, the deliciousness and texture of the granular oral food G mainly composed of natto Aa can be improved.

また、顆粒状経口食品Gは、図3に示すように、中心核であるケールBの微粉末Baの周面全体に対し混合物Dの濃縮された層を形成しているので、顆粒状経口食品Gを少量経口投与するだけでも、必要な成分を摂取することができる。また、微粉末Baの周面全体に形成された混合物Dの層が外側から徐々に溶解するので、混合物Dに含まれる成分の効果が長い時間継続して得られる。   In addition, as shown in FIG. 3, the granular oral food G forms a concentrated layer of the mixture D over the entire peripheral surface of the fine powder Ba of the kale B, which is the central core. Necessary components can be ingested only by oral administration of a small amount of G. Moreover, since the layer of the mixture D formed on the entire peripheral surface of the fine powder Ba is gradually dissolved from the outside, the effects of the components contained in the mixture D can be continuously obtained for a long time.

前記製造方法で製造された顆粒状経口食品Gの経口投与によって得られる効果としては、例えば便通、冷え性、生理痛、糖尿病、脱毛、アトピー、花粉症、自律神経失調症、膠原病、脳梗塞、坐骨神経痛、痛風、癌、白内障、高血圧、肺動脈瘤等がある。   Examples of the effects obtained by oral administration of the granular oral food G produced by the production method include, for example, bowel movement, coldness, menstrual pain, diabetes, hair loss, atopy, hay fever, autonomic dysfunction, collagen disease, cerebral infarction, There are sciatica, gout, cancer, cataracts, hypertension, pulmonary aneurysms and the like.

便通の場合、1週間〜2週間、排便がなかっても、顆粒状経口食品Gを朝昼夜に所定量経口投与した結果、便が2日〜3日で出るようになり、毎朝便通があり、便秘が解消されるという効果が得られる。   In the case of bowel movements, even if there is no bowel movement for 1 to 2 weeks, as a result of oral administration of a predetermined amount of granular oral food G in the morning and night, the stool comes out in 2 to 3 days, there is a bowel movement every morning, The effect of eliminating constipation is obtained.

冷え性の場合、足首から下が冷たく夜靴下を履いていた。特に冬は2枚重ねて履いていたが、顆粒状経口食品Gを朝昼夜に所定量経口投与した結果、1日〜2日で足首から下が暖かく靴下を履かなくても熟睡することが出来るようになるという効果が得られる。   In the case of coldness, the socks were cold from the ankles and he was wearing socks at night. Especially in winter, two sheets were worn, but as a result of oral administration of a predetermined amount of granular oral food G in the morning and day and night, the lower part of the ankle is warm from 1 to 2 days, so you can sleep well without wearing socks. The effect of becoming like this is acquired.

生理痛の場合、生理が不規則で、有る月と無い月があり、また周期も早くなったり遅くなったり、そして、生理痛は2週間も続くことがあったが、顆粒状経口食品Gを朝昼夜に所定量経口投与した結果、2ヶ月目からは生理痛がなくなり生理不順もなく、きちっと28日周期で規則正しくなるという効果が得られる。   In the case of menstrual pain, menstruation is irregular, there are some months, some months are not, and the cycle is earlier or later, and menstrual pain may last as long as two weeks. As a result of oral administration of a predetermined amount in the morning and night, from the second month, there is no menstrual pain and no menstrual irregularities, and the effect of regularity with a period of 28 days is obtained.

糖尿病の場合、糖尿病で壊疽になり、足の親指の元から切断しなければならないと診断されたが、顆粒状経口食品Gを朝昼夜に所定量経口投与した結果、冷たかった足が温かくなり、切断しなくても良くなるという効果が得られる。   In the case of diabetes, it was diagnosed that it became gangrene due to diabetes and had to be cut from the base of the big toe, but as a result of oral administration of a predetermined amount of granular oral food G in the morning and night, the cold foot became warm, The effect that it does not need to cut | disconnect is acquired.

脱毛の場合、抜け毛が気になって髪が少なくなってきて、白髪も急に前のほうから増えてきたが、顆粒状経口食品Gを朝昼夜に所定量経口投与すると3ヶ月位で黒い髪が増え、6ヶ月経過した時には、前と両サイドの白髪が減少し、黒髪に変化するという効果が得られる。   In the case of hair loss, hair loss has become less worrisome, and gray hair has suddenly increased from the front, but when oral administration of granular oral food G in the morning and noon is given orally in about 3 months, black hair When 6 months have passed, the front and both sides of the white hair are reduced, and the effect of changing to black hair is obtained.

アトピーの場合、全身アトピーで頭の頭皮がボコボコしていましたが、顆粒状経口食品Gを1日に所定量経口投与した結果、3ヶ月後、頭の痒みとボコボコ感が無くなり、耳の後ろの痒みもなくなるという効果が得られる。   In the case of atopy, the scalp of the scalp was lumpy due to whole body atopy, but as a result of oral administration of a predetermined amount of granular oral food G per day, the head itch and tingling sensation disappeared after 3 months, and the back of the ear The effect of eliminating the grudge is obtained.

花粉症の場合、早い年で1月中旬頃より鼻水が出て、目の周りが痒くなり、風邪も引きやすくなり一旦風邪を引くと状態が長く痰もよく出ていたが、顆粒状経口食品Gを朝昼夜と1日に所定量経口投与し続けた結果、鼻水も出なくなり、目の周りの痒みも無くなり、風邪も引かなくなり、痰も出なくなるという効果が得られる。   In the case of hay fever, a runny nose started in mid-January early in the year, and the area around the eyes became ugly, and it was easy to catch a cold. As a result of continuing oral administration of a predetermined amount of G in the morning, day, night and day, the effects of no runny nose, no itching around the eyes, no colds, and no wrinkles are obtained.

自律神経失調症の場合、暗い所に1週間もじっとしていなければ落ち着かず、また不眠の状態が続いていたが、顆粒状経口食品Gを朝昼夜と1日に所定量経口投与し続けて4ヶ月が経過したころから症状はなくなるという効果が得られる。   In the case of autonomic dysfunction, if the patient stayed in a dark place for a week, he / she remained calm and insomnia continued. The effect that the symptom disappears from about 4 months has been obtained.

膠原病の場合、6年間病院に通っていましたが、快方に向かわず、そこで、顆粒状経口食品Gを朝昼夜と1日に所定量経口投与し続けて4ヶ月、驚くくらい症状が改善されるという効果が得られる。   In the case of collagen disease, I went to the hospital for 6 years, but it wasn't going to be good, so I continued to administer a predetermined amount of granular oral food G in the morning and night and daily for 4 months, and my symptoms improved dramatically. The effect that it is done is acquired.

脳梗塞の場合、64歳で脳梗塞になり、右手右足が不自由になり、字を書いたり、物を掴む時に手が震えたり、右手を上げる時、痛みが激しく刺すような痛みだった。しかし、顆粒状経口食品Gを朝昼夜と1日に所定量経口投与し続けた結果、手の震えが少なく物を掴む時につかみやすくなり、右手を上げる時の痛みが軽くなり、体全体が暖かく特に下の部分が暖かくなり、水風呂に足をつけてもしばらくは耐えられるようになるという効果が得られる。   In the case of cerebral infarction, he became cerebral infarction at the age of 64, and his right hand and right foot became inconvenient, and his hand trembled when writing or grabbing an object, and when he raised his right hand, the pain was stinging. However, as a result of continuous oral administration of granular oral food G in the morning, day, night and day, it is easy to grasp when grasping an object with little shaking of the hand, lightening the pain when raising the right hand, and warming the whole body In particular, the lower part becomes warm, and even if you put your foot on the water bath, you will be able to withstand for a while.

坐骨神経痛の場合、朝起き上がる時に、腰から足先までビリビリ電気が走るような痛みがあり、尿酸値も高く、足の関節も痛く、体が重くだるさがあった。しかし、顆粒状経口食品Gを朝昼夜と1日に所定量経口投与するようになってからは、足首から下が1週間位で暖かくなり、腰の痛みが1ヶ月位で少なくなり、3ヶ月でほとんど感じなくなるという効果が得られる。   In the case of sciatica, when waking up in the morning, there was a pain that electric power was running from the waist to the toes, the uric acid level was high, the joints of the feet were also painful, and the body was heavy. However, after the oral administration of granular oral food G in the morning, day, night and day, the lower part from the ankle becomes warm in about one week, and the lower back pain is reduced in about one month. The effect of almost not feeling is obtained.

痛風の場合、足の甲の痛みが激しく、足首の下が特に冷えて右足には20kg位のオモリを付けているのかと思えるくらいであった。しかし、顆粒状経口食品Gを朝昼夜と1日に所定量経口投与するようになってからは、1ヶ月位して痛みが少なくなり、3ヶ月経過した頃にはほとんど感じなくなるという効果が得られる。   In the case of gout, the pain in the instep was so severe that it seemed that the bottom of the ankle was particularly cold and the right foot had a weight of about 20 kg. However, after a certain amount of granular oral food G is orally administered in the morning, day, night and day, there is an effect that the pain is reduced after about one month, and almost no feeling is felt after three months. It is done.

癌の場合、2年前に胃癌にかかり全摘したが、その後、検査で再発が見つかり、現在抗癌剤を使った治療を3週間毎に繰り返していた。また、以前から足が冷たく、また腸の動きが悪く、そのため抗癌剤を投与してから3日〜4日は寝たまま、起き上がることも出来ない状態であった。
その後、顆粒状経口食品Gを1日に所定量経口投与してからは、4日目位に足が暖かくなってきたことに気づき、腸の動きも以前より良く動いて以前には無かった空腹感が出てきた。また、抗癌剤投与後も今は以前のように副作用がひどく起き上がれなくなることも少なくなるという効果が得られる。
In the case of cancer, gastric cancer was removed 2 years ago, and after resection, recurrence was found in the test, and treatment with anticancer agents was now repeated every 3 weeks. In addition, the legs have been cold for a long time and the intestinal movement has been poor, and therefore, the patient has been unable to get up while lying asleep for 3-4 days after administration of the anticancer drug.
Then, after oral administration of a predetermined amount of granular oral food G per day, I noticed that my feet were getting warmer around the 4th day, and my intestinal movement moved better than before, and I had never been hungry. A feeling came out. Moreover, even after administration of the anticancer agent, there is an effect that the side effects are not so severely raised as before.

白内障の場合、55歳の時に、メガネを掛けていても見にくくなり、視力が低下しただけだと思って診察に行くと、医師から白内障と診断され目薬をもらった。また、幸いにもまだ早期で手術をするほどではなかったが、顆粒状経口食品Gを半年位飲んでいると視力が回復するという効果が得られる。   In the case of cataracts, when he was 55 years old, it was difficult to see even if he was wearing glasses, and when he went to seeing that his vision had only deteriorated, he was diagnosed as having cataract and received eye drops. Fortunately, although it was not so early as surgery, the effect of recovering visual acuity is obtained when the granular oral food G is taken for about six months.

高血圧の場合、会社の健康診断で高血圧と診断され病院へ行った際に、血圧の薬を飲むと飲み続けなければ効果が得られないと言われた。そこで、顆粒状経口食品Gを、出張の際も小袋へ入れる等して、毎日、所定量経口投与するようになってからは、3ヶ月位からひどかった肩こりが無くなくなり、血圧がほぼ正常値になるという効果が得られる。   In the case of high blood pressure, when he was diagnosed with high blood pressure at a company health checkup and went to the hospital, he was told that if he took medicine for blood pressure, he would not be effective unless he took it. Therefore, the granular oral food G is put in a small bag even on a business trip, etc., and after a prescribed amount is orally administered every day, the stiff shoulder stiffness disappears from about 3 months and blood pressure is almost normal. The effect of becoming.

肺動脈瘤の場合、息苦しさから病院で検査を受けると、肺動脈瘤があることがわかり、投薬しながら経過を見て手術するようになっていました。そこで、顆粒状経口食品Gを、毎日、朝昼夜と食前に所定量経口投与するようになってからは、2ヶ月後の検査で動脈瘤が消えるという効果が得られる。なお、前記のような症状が改善する日数、期間には個人差がある。   In the case of a pulmonary aneurysm, when I was examined at the hospital because of the difficulty of breathing, I found that there was a pulmonary aneurysm, and I started to operate while watching the progress while taking medication. Therefore, after the granular oral food G is orally administered every day, in the morning, noon, and before meals, an aneurysm disappears in an examination two months later. In addition, there are individual differences in the number of days and the period in which the above symptoms are improved.

この発明の構成と、前記実施例との対応において、
この発明の動物は、実施例の牛に対応し、
以下同様に、
動物の乳は、牛の牛乳に対応し、
植物は、ケールBに対応し、
天然甘味料は、有機黒糖Cに対応するも、
この発明は、前記実施例の構成のみに限定されるものではなく、請求項に示される技術思想に基づいて応用することができ、多くの実施の形態を得ることができる。
In the correspondence between the configuration of the present invention and the above embodiment,
The animal of this invention corresponds to the cow of the example,
Similarly,
Animal milk corresponds to cow's milk,
The plant corresponds to Kale B,
Natural sweetener corresponds to organic brown sugar C,
The present invention is not limited to the configuration of the above-described embodiment, but can be applied based on the technical idea shown in the claims, and many embodiments can be obtained.

前記実施例の大豆に代えて、有機栽培された黒豆を原料として用いてもよい。大豆や黒豆には、例えばイソフラボン、γ−アミノ酪酸(GABA)、必須アミノ酸、サポニン、たんぱく質、脂質、炭水化物、ナトリウム、カリウム、カルシウム、マグネシウム、ビタミンE、レシチン等の成分が多く含まれているので、略同等の作用及び効果を奏することができる。   Instead of the soybean of the above embodiment, organically cultivated black beans may be used as a raw material. Soy beans and black beans contain many components such as isoflavones, γ-aminobutyric acid (GABA), essential amino acids, saponins, proteins, lipids, carbohydrates, sodium, potassium, calcium, magnesium, vitamin E, and lecithin. The substantially equivalent operation and effect can be achieved.

また、ケールAの微粉末Aaで中心核を形成する際に、例えばデキストリン、デンプン類、糖類等の賦形剤(添加剤)を添加してもよい。   Further, when forming the central core with the fine powder Aa of Kale A, excipients (additives) such as dextrin, starches, and saccharides may be added.

b…第1混合工程
c…添加工程
d…発酵工程
e…第2混合工程
f…熱処理工程
g…顆粒化工程
h…顆粒粉砕工程
i…食品化工程
j…植物乾燥工程
k…植物粉砕工程
Aa…納豆
Ab…ヨーグルト
Ac…イースト菌
B…ケール
Ba…微粉末
C…有機黒糖
D…混合物
E…発酵混合物
G…顆粒状経口食品
G3…粉末状経口食品
b ... first mixing step c ... addition step d ... fermentation step e ... second mixing step f ... heat treatment step g ... granulation step h ... granule pulverization step i ... food conversion step j ... plant drying step k ... plant pulverization step Aa ... Natto Ab ... Yogurt Ac ... Yeast B ... Kale Ba ... Fine powder C ... Organic brown sugar D ... Mixture E ... Fermentation mixture G ... Granular oral food G3 ... Powdered oral food

Claims (10)

蒸し処理された有機栽培の大豆を納豆菌により発酵してなる納豆と、動物から搾乳された乳を乳酸菌により発酵してなるヨーグルトと、単一種を培養してなるイースト菌とを混合する第1の混合工程と、
前記第1の混合工程にて混合された液状の混合物に粉末状の植物を添加する添加工程と、
前記添加工程にて植物が添加された混合物を適温に保ちながら発酵する発酵工程と、
前記発酵工程にて発酵された混合物を、該混合物に含まれる菌の活動が停止又は抑えられる温度で熱処理する熱処理工程と、
前記熱処理工程にて熱処理された混合物を顆粒状に加工する顆粒化工程とを備えたことを特徴とする
顆粒状経口食品の製造方法。
A first mixture of natto fermented steamed organic soybeans with natto bacteria, yogurt fermented with lactic acid bacteria from milk milked from animals, and yeast produced by culturing a single species A mixing step;
An adding step of adding a powdery plant to the liquid mixture mixed in the first mixing step;
A fermentation process in which the mixture to which plants are added in the addition process is fermented while maintaining a suitable temperature;
A heat treatment step of heat-treating the mixture fermented in the fermentation step at a temperature at which the activity of the bacteria contained in the mixture is stopped or suppressed;
And a granulating step of processing the mixture heat-treated in the heat treatment step into a granule.
前記添加工程にて混合物に植物を添加する際に、該混合物と植物を8:10の重量比で混合することを特徴とする
請求項1に記載の顆粒状経口食品の製造方法。
The method for producing a granular oral food according to claim 1, wherein when the plant is added to the mixture in the addition step, the mixture and the plant are mixed at a weight ratio of 8:10.
前記添加工程にて混合物に植物を添加する際に、有機栽培の農産物から抽出された天然甘味料を添加することを特徴とする
請求項1又は2に記載の顆粒状経口食品の製造方法。
The method for producing a granular oral food according to claim 1 or 2, wherein a natural sweetener extracted from an organically grown agricultural product is added when a plant is added to the mixture in the adding step.
前記発酵工程にて発酵された混合物に、粉末状の植物を混合する第2の混合工程を備えたことを特徴とする
請求項1に記載の顆粒状経口食品の製造方法。
The method for producing a granular oral food according to claim 1, further comprising a second mixing step of mixing the powdered plant with the mixture fermented in the fermentation step.
前記混合物に添加される植物に遠赤外線を照射して、該植物を所望する水分量に乾燥する植物乾燥工程を備えたことを特徴とする
請求項1〜4のいずれか一つに記載の顆粒状経口食品の製造方法。
The plant according to any one of claims 1 to 4, further comprising a plant drying step of irradiating the plant added to the mixture with far-infrared rays to dry the plant to a desired water content. A method for producing oral food.
前記混合物に添加される植物を粉末状に粉砕する植物粉砕工程を備えたことを特徴とする
請求項1〜5のいずれか一つに記載の顆粒状経口食品の製造方法。
The method for producing a granular oral food according to any one of claims 1 to 5, further comprising a plant crushing step of crushing the plant added to the mixture into a powder form.
蒸し処理された有機栽培の大豆を納豆菌により発酵してなる納豆と、動物から搾乳された乳を乳酸菌により発酵してなるヨーグルトと、単一種を培養してなるイースト菌とが混合された液状の混合物に、粉末状の植物を加えて発酵させた後、
前記植物が加えられた混合物を、該混合物に含まれる菌の活動が停止又は抑えられる温度で熱処理して顆粒状に加工したことを特徴とする
顆粒状経口食品。
A liquid mixture of natto fermented steamed organic soybeans with natto bacteria, yogurt fermented with lactic acid bacteria from milk milked from animals, and yeast produced by culturing a single species After the mixture is fermented with powdered plants,
A granular oral food, wherein the mixture to which the plant is added is processed into granules by heat treatment at a temperature at which the activity of the bacteria contained in the mixture is stopped or suppressed.
前記混合物と植物を8:10の重量比で混合したことを特徴とする
請求項7に記載の顆粒状経口食品。
The granular oral food according to claim 7, wherein the mixture and the plant are mixed at a weight ratio of 8:10.
前記混合物に、有機栽培の農産物から抽出された天然甘味料を添加したことを特徴とする
請求項7又は8に記載の顆粒状経口食品。
The granular oral food according to claim 7 or 8, wherein a natural sweetener extracted from organically grown agricultural products is added to the mixture.
前記混合物に、遠赤外線の照射によって所望する水分量に乾燥された植物を添加したことを特徴とする
請求項7〜9のいずれか一つに記載の顆粒状経口食品。
The granular oral food according to any one of claims 7 to 9, wherein a plant dried to a desired water content by irradiation with far infrared rays is added to the mixture.
JP2009187212A 2009-08-12 2009-08-12 Method for producing granular oral food and granular oral food produced by the method Pending JP2011036190A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009187212A JP2011036190A (en) 2009-08-12 2009-08-12 Method for producing granular oral food and granular oral food produced by the method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009187212A JP2011036190A (en) 2009-08-12 2009-08-12 Method for producing granular oral food and granular oral food produced by the method

Publications (1)

Publication Number Publication Date
JP2011036190A true JP2011036190A (en) 2011-02-24

Family

ID=43764674

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009187212A Pending JP2011036190A (en) 2009-08-12 2009-08-12 Method for producing granular oral food and granular oral food produced by the method

Country Status (1)

Country Link
JP (1) JP2011036190A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITCN20120016A1 (en) * 2012-11-26 2014-05-27 Alessio Lilliu MANUFACTURING PROCESS AT THE CREATION OF HYPOCALORIC FOOD PRODUCTS AND / OR SUITABLE FOR DIABETIC PATIENTS, ARISING FROM RAW MATERIALS SUBJECT TO BIOCHEMICAL MODIFICATION OF THE SUBSTRATE BY YEAST AND, FOLLOWING, MADE STABLE AND SAFE.
CN109557014A (en) * 2019-01-24 2019-04-02 广东产品质量监督检验研究院(国家质量技术监督局广州电气安全检验所、广东省试验认证研究院、华安实验室) A kind of method of lactic acid bacteria number in quick detection acidified milk

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01291764A (en) * 1988-05-18 1989-11-24 Amano Jitsugyo Kk Production of novel fermented food
JP2001178410A (en) * 1999-12-24 2001-07-03 Takashi Kondo Method for producing health food
JP2002369663A (en) * 2001-06-15 2002-12-24 Kenko Hyakunijussai:Kk Base food for health care and combined health promotion food
JP2003259835A (en) * 2001-12-28 2003-09-16 Oubiken:Kk Production of fermented product and its utilization
WO2005000042A1 (en) * 2003-06-30 2005-01-06 Otsuka Pharmaceutical Co., Ltd. Composition containing lactic acid bacterium producing equol
WO2009001495A1 (en) * 2007-06-26 2008-12-31 Enseki Aojiru Co., Ltd. Method for producing composition-coated tea and composition-coated tea

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01291764A (en) * 1988-05-18 1989-11-24 Amano Jitsugyo Kk Production of novel fermented food
JP2001178410A (en) * 1999-12-24 2001-07-03 Takashi Kondo Method for producing health food
JP2002369663A (en) * 2001-06-15 2002-12-24 Kenko Hyakunijussai:Kk Base food for health care and combined health promotion food
JP2003259835A (en) * 2001-12-28 2003-09-16 Oubiken:Kk Production of fermented product and its utilization
WO2005000042A1 (en) * 2003-06-30 2005-01-06 Otsuka Pharmaceutical Co., Ltd. Composition containing lactic acid bacterium producing equol
WO2009001495A1 (en) * 2007-06-26 2008-12-31 Enseki Aojiru Co., Ltd. Method for producing composition-coated tea and composition-coated tea
WO2009001494A1 (en) * 2007-06-26 2008-12-31 Enseki Aojiru Co., Ltd. Method for producing granular oral food and granular oral food

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITCN20120016A1 (en) * 2012-11-26 2014-05-27 Alessio Lilliu MANUFACTURING PROCESS AT THE CREATION OF HYPOCALORIC FOOD PRODUCTS AND / OR SUITABLE FOR DIABETIC PATIENTS, ARISING FROM RAW MATERIALS SUBJECT TO BIOCHEMICAL MODIFICATION OF THE SUBSTRATE BY YEAST AND, FOLLOWING, MADE STABLE AND SAFE.
CN109557014A (en) * 2019-01-24 2019-04-02 广东产品质量监督检验研究院(国家质量技术监督局广州电气安全检验所、广东省试验认证研究院、华安实验室) A kind of method of lactic acid bacteria number in quick detection acidified milk

Similar Documents

Publication Publication Date Title
CN1322821C (en) Natto powder and preparing method and health food containing such natto powder
CN103749982B (en) Feed for improving egg yield, traditional Chinese medicine additive and preparation method thereof
KR101374424B1 (en) Method for health food using rice bran and embryo and linseed
US20160037811A1 (en) Fruit and vegetable product for curing oral ulcer, and preparation method therefor
CN102726799A (en) Pure natural beverage capable of improving dietary structure and conditioning diet property and flavor
CN104095239A (en) Health-care food with efficacy of maintaining beauty, caring skin, molding body and losing weight and preparation method thereof
CN110037113A (en) A kind of Ms&#39;s weight reducing face-beautifying milk powder
KR20170072003A (en) Method of manufacturing a fermented food that can help diabetes using the Hordeum vulgare L. and fermented food that has been produced by it
CN104472612A (en) Natural yeast bread premixed flour for bread capable of coordinating intestines and stomach
CN108902732A (en) A kind of blueness juice noodles and preparation method thereof
CN108541912A (en) A kind of anti-oxidant blood-fat reducing composition and its preparation method and application
CN104489472B (en) It is a kind of to be used to improve indigestion, the food of diarrhoea
KR101115450B1 (en) Cereal composition for portion packaging with tea and porridge functions and preparation thereof
JP2011036190A (en) Method for producing granular oral food and granular oral food produced by the method
CN110037139A (en) A kind of health tea and its production technology
JP4961476B2 (en) Granular oral food manufacturing method and granular oral food
CN107348490A (en) A kind of compound calcium
CN107347997A (en) Milk containing high-calcium aizoon stonecrop herb and preparation method thereof
CN114009509A (en) Formula milk powder capable of improving immunity, strengthening muscles and bones and assisting sleep and preparation method of formula milk powder
CN102885364A (en) Corn beverage and its preparation method
KR20170130756A (en) The method of functional korea traditional cracker using the jujube
CN112189843A (en) Raspberry nutritional chewable tablet and preparation method thereof
KR20210084942A (en) The manufacturing method of making healthcare food composition for costitutional group
CN103518893A (en) Formula and production method of mint tea for clearing away heart-fire and refreshing spirit
KR101394202B1 (en) Health supplement foods using natural material

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120515

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20121106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121113

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130625

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140107